These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 9703957

  • 1. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T, Melck D, De Petrocellis L, Bobrov MYu, Gretskaya NM, Bezuglov VV, Sitachitta N, Gerwick WH, Di Marzo V.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):515-22. PubMed ID: 9703957
    [Abstract] [Full Text] [Related]

  • 2. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T, Melck D, Bobrov MYu, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V.
    Biochem J; 2000 Nov 01; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [Abstract] [Full Text] [Related]

  • 3. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
    De Petrocellis L, Melck D, Ueda N, Maurelli S, Kurahashi Y, Yamamoto S, Marino G, Di Marzo V.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):82-8. PubMed ID: 9070224
    [Abstract] [Full Text] [Related]

  • 4. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S, De Petrocellis L, de Novellis V, Moriello AS, Petrosino S, Palazzo E, Rossi FS, Woodward DF, Di Marzo V.
    Br J Pharmacol; 2007 Mar 03; 150(6):766-81. PubMed ID: 17279090
    [Abstract] [Full Text] [Related]

  • 5. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
    Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L.
    Biochem J; 1998 Apr 01; 331 ( Pt 1)(Pt 1):15-9. PubMed ID: 9512456
    [Abstract] [Full Text] [Related]

  • 6. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
    Gobira PH, Lima IV, Batista LA, de Oliveira AC, Resstel LB, Wotjak CT, Aguiar DC, Moreira FA.
    J Psychopharmacol; 2017 Jun 01; 31(6):750-756. PubMed ID: 28583049
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R, De Petrocellis L.
    FEBS Lett; 1998 Oct 09; 436(3):449-54. PubMed ID: 9801167
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK, Kidd SR, Moore SA, Schaus JM, Liu B, Nomikos GG, Felder CC.
    Cell Mol Neurobiol; 2006 Oct 09; 26(4-6):407-23. PubMed ID: 16736384
    [Abstract] [Full Text] [Related]

  • 10. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N, Kostrzewa M, Makuch W, Pajak A, Kucharczyk M, Piscitelli F, Przewlocka B, Di Marzo V, Starowicz K.
    Pharmacol Res; 2016 Sep 09; 111():251-263. PubMed ID: 27326920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
    Lichtman AH, Hawkins EG, Griffin G, Cravatt BF.
    J Pharmacol Exp Ther; 2002 Jul 09; 302(1):73-9. PubMed ID: 12065702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ, Tiger G, Ligresti A, López-Rodríguez ML, Di Marzo V.
    Eur J Pharmacol; 2004 May 10; 492(1):1-11. PubMed ID: 15145699
    [Abstract] [Full Text] [Related]

  • 17. New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain.
    Ortar G, Cascio MG, De Petrocellis L, Morera E, Rossi F, Schiano-Moriello A, Nalli M, de Novellis V, Woodward DF, Maione S, Di Marzo V.
    J Med Chem; 2007 Dec 27; 50(26):6554-69. PubMed ID: 18027904
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.